CLINICAL_TRIALS
trial_result
· 2026-07-22
Clinical Trial Results: PROMUS PREMIER™ China Post-Approval Study
Summary
Post-approval study results for PROMUS PREMIER in China evaluating outcomes in patients with coronary artery disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Coronary Artery Disease | Status: COMPLETED | Results posted: 2026-07-22